Amoéba enters into agreements with Bayer and Syngenta


Amoéba has entered into a material transfer agreement with Bayer to evaluate the performance of Amoéba’s biocontrol solutions containing the amoeba lysate Willaertia magna C2c Maky.

The trials, conducted by Bayer’s Crop Science division, will be carried out on various pathogens affecting crops.

Amoéba has also signed an evaluation and testing agreement with Syngenta whereby Syngenta will test different concepts based on Amoeba's Willaertia magna C2c Maky amoeba lysate. Amoeba’s proprietary biocontrol technology will be integrated into Syngenta trial protocols for evaluation at several sites across Europe.

Amoéba is still in the testing phase for its biocide and biocontrol applications and does not currently market any products.

More information:

 Certified Crop Advisors - earn CEUs credits HERE! 

Check out our new digital publication in Spanish HERE!

cover 199x282



NAI56 Cover199x282


News From Suppliers